Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

Share Price is delayed by 15 minutes
Get Live Data
100.60    -2.60 (-2.52%)
Bid:
101.00
Ask:
101.80
Spread: 0.80 (0.792%)
Market Cap: £164.93m
SYNT Live PriceLast checked at - London Stock Exchange

Intraday Synthomer Share Chart

Directorate Change

16 Jan 2014 07:00

RNS Number : 7722X
Synthomer PLC
16 January 2014
 



 

16th January 2014

 

Synthomer plc

 

Directorate change

 

Appointment of Brendan Connolly as an Independent Non-executive Director

 

 

Synthomer plc ("Synthomer" or the "Company") is pleased to announce that Brendan Connolly will join the Board as an Independent Non-executive Director with effect from 20 January 2014.

 

Brendan was, until June 2013, a senior executive at Intertek Group PLC and had previously been Chief Executive Officer of Moody International (which was acquired by Intertek in 2011). Prior to Intertek, Brendan spent more than 25 years of his career with Schlumberger in senior international roles over three continents.

 

Brendan holds non-executive directorships at Sparrows Offshore Group Ltd and Cape plc and also chairs the Remuneration Committee at the latter.

 

Commenting on the appointment, Neil Johnson, Chairman, said:

 

"I am delighted to welcome Brendan to the Board and we look forward to benefitting from both his international business and board room experience."

 

There are no details to be notified under Listing Rule 9.6.13 in relation to Mr Connolly's appointment.

 

 

Enquires:

 

Synthomer plc

Adrian Whitfield, Chief Executive

Tel: +44 (0)1279 436211

 

Pendomer Communications

Charlie Armitstead

Tel: +44 (0)203 603 5224

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAUVUBRSKAAAAR
Date   Source Headline
1st Jun 20262:42 pmRNSHolding(s) in Company
29th May 20263:57 pmRNSTotal Voting Rights
22nd May 20265:21 pmRNSNotice of AGM
8th May 20264:33 pmRNSAdmission to Trading
7th May 20261:51 pmRNSApplication for Admission to Trading
5th May 20264:25 pmRNSHolding(s) in Company
30th Apr 20264:40 pmRNSAnnual Financial Report
30th Apr 20263:17 pmRNSDirector/PDMR Shareholding
30th Apr 202611:25 amRNSDirector/PDMR Shareholding
30th Apr 20267:01 amRNSChange of Chief Financial Officer
30th Apr 20267:00 amRNSFinal Results
19th Mar 20267:00 amRNSTrading and refinancing update
11th Feb 20261:46 pmRNSStatement re potential refinancing
29th Jan 20267:00 amRNSTrading Statement - Winter 2026
27th Jan 20264:51 pmRNSHolding(s) in Company
26th Jan 20264:23 pmRNSHolding(s) in Company
18th Dec 20257:00 amRNSReceivables purchasing arrangement
12th Dec 20259:30 amRNSDirectorate change
12th Nov 20257:00 amRNSDirector/PDMR Shareholding
5th Nov 20251:28 pmRNSHolding(s) in Company
23rd Oct 20257:00 amRNSTrading statement - Autumn 2025
14th Oct 20257:00 amRNSAppointment of joint corporate broker
4th Sep 20255:17 pmRNSHolding(s) in Company
11th Aug 20258:00 amRNSDirector/PDMR Shareholding
6th Aug 20259:45 amRNSDirector/PDMR Shareholding
5th Aug 202511:57 amRNSDirector/PDMR Shareholding
5th Aug 202511:00 amRNSDirectorate Change
5th Aug 20257:00 amRNSInterim results
4th Jul 20257:01 amRNSDirector/PDMR Shareholding
1st Jul 20257:00 amRNSCovenant update
30th Jun 20257:00 amRNSDirectorate Changes
27th Jun 20254:21 pmRNSHolding(s) in Company
2nd Jun 20257:00 amRNSDivestment of William Blythe completed
6th May 20257:00 amRNSDivestment of William Blythe
1st May 20254:18 pmRNSResults of AGM
1st May 20257:00 amRNSTrading Statement - Spring 2025
15th Apr 20253:00 pmRNSHolding(s) in Company
28th Mar 20257:30 amRNSDirector/PDMR Shareholding
27th Mar 20257:30 amRNSDirector/PDMR Shareholding
25th Mar 20254:23 pmRNSAnnual Report and Notice of AGM
25th Mar 202511:43 amRNSDirector/PDMR Shareholding
25th Mar 202511:41 amRNSDirector/PDMR Shareholding
24th Mar 20257:30 amRNSHolding(s) in Company
17th Mar 20259:00 amRNSDirector/PDMR Shareholding
17th Mar 20259:00 amRNSDirector/PDMR Shareholding
11th Mar 20257:00 amRNSFinal Results
6th Mar 20258:32 amRNSDirector Declaration
13th Feb 20257:00 amRNSHolding(s) in Company
28th Jan 202510:30 amRNSDirector/PDMR Shareholding
28th Jan 20257:00 amRNSWinter trading statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.